Choksi Laboratories Limited’s Board of Directors convened on August 13, 2026, approving the unaudited financial results for the quarter ended June 30, 2026. The company also finalized the date for its 33rd Annual General Meeting (AGM) to be held on September 18, 2026, via video conferencing.
Board Meeting Outcome: Q1 FY27 Financials Approved
The Board of Directors of Choksi Laboratories Limited met on Thursday, August 13, 2026, at the company’s registered office in Indore. During this meeting, the Board considered and approved the Unaudited Financial Results for the Quarter ended on June 30, 2026, along with the associated Limited Review Report.
Key Decisions and Appointments
The Board also resolved to close the Register of Members and share transfer books from September 12, 2026, to September 18, 2026, inclusive, in preparation for the upcoming 33rd Annual General Meeting (AGM). The cut-off date and remote e-voting period for the AGM were also finalized.
Further approvals included the Board’s Report, Corporate Governance Report, and the Management Discussion & Analysis Report (MDAR) for the financial year ended March 31, 2026. The notice for the 33rd AGM was approved, with the meeting scheduled for Friday, September 18, 2026, to be conducted via Video Conferencing (VC) or Other Audio-Visual Means (OAVM).
In personnel matters, Ms. Himika Choksi was re-appointed as Whole Time Director for a further five-year term effective April 1, 2027, subject to shareholder approval. M/s Tanmay V. Rajurkar & Co. were approved as Internal Auditors for the Financial Year 2026-27. Additionally, CS Surabhi Agrawal was appointed as Scrutinizer for the e-voting process at the AGM.
Registrar and Share Transfer Agent Change Noted
The Board took note of the change in the company’s Registrar and Share Transfer Agent from MUFG Intime India Private Limited to Ankit Consultancy Private Limited. Other operational, financial, and administrative matters were also discussed, with necessary resolutions passed.
Financial Results Submission and Disclosure
Copies of the Unaudited Financial Results will be submitted in XBRL mode within 24 hours of the Board Meeting’s conclusion. The results will also be uploaded on the company’s website, www.choksilab.in, and the Stock Exchange website, www.bseindia.com. A public notice containing a Quick Response code and webpage details will be published in Hindi and English newspapers.
Limited Review Report
The unaudited financial results for the quarter ended June 30, 2026, were subjected to a ‘Limited Review’ by the auditors, Prateek Jain & Co. Their report, dated August 13, 2026, indicated that nothing came to their attention to suggest material misstatements, and the results were prepared in accordance with applicable accounting principles.
Financial Highlights (Quarter Ended June 30, 2026)
Revenue and Profitability
Total Revenue from Operations for the quarter stood at ₹1207.89 Lakhs. Total Expenses amounted to ₹1147.96 Lakhs, resulting in a Profit Before Tax of ₹59.93 Lakhs. After accounting for Tax Expenses of ₹9.45 Lakhs, the Net Profit for the period from continuing operations was ₹50.49 Lakhs. Total Comprehensive Income was ₹58.91 Lakhs.
Earnings Per Share (EPS)
Basic Earnings Per Share (EPS) for continuing operations was ₹0.84, and Diluted EPS was also ₹0.84.
Source: BSE
